ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
Centre for Addiction and Mental Health at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
Centre for Addiction and Mental Health brings 7 presentations from 3 research groups to ASHG 2026 in Montréal. Its program centres on computational and population genetics, clinical genetics, and psychiatric therapeutics. The Tanenbaum Centre for Pharmacogenetics examines CYP2D6 and CYP2C19 variation, the Tripathy Lab studies rare variants in consanguineous families, and Molecular Neuropsychiatry & Development (MiND) Lab analyses MECP2 mutations.
| Organization | ASHG 2026 Attendance |
|---|---|
Centre for Addiction and Mental Health Toronto, Ontario | 2 Staff Scientists · 2 Postdocs · 2 PhD Students |
Tanenbaum Centre for Pharmacogeneticscamh.ca/en/science-and-research/institutes-and-centres/tanenbaum-centre-for-pharmacogenetics Studies genetic, epigenetic and gene-expression data to guide psychiatric medication response. Uses IMPACT pharmacogenetic testing and large patient cohorts for personalized mental-health treatment.
| Poster Wed Oct 21 2:30 pm Repeat Expansion Diseases and Psychiatric Disorders — a scoping review Triplet and other repeats Poster Wed Oct 21 2:30 pm Pharmacogenomic Variation in CYP2D6 and CYP2C19 Is Highly Prevalent in Adults with Neurodevelopmental Disorders and Associated with Increased Psychotropic Treatment Complexity PharmacogenomicsNeurodevelopmentalAutismGenetic variation Poster Thu Oct 22 4:15 pm Integrating Immune Gene Expression and Polygenic Risk to Investigate Neuroimmune Mechanisms in Schizophrenia Polygenic risk scorePsychiatric geneticsImmune systemBrain/nervous system |
Tripathy Labtriplab.org Uses single-cell RNA-sequencing, spatial transcriptomics, long-read sequencing and UK Biobank data. Develops machine-learning methods for brain cell types, neurodevelopmental disorders and psychiatric illness.
| Poster Thu Oct 22 4:15 pm Ultima Genomics whole-genome sequencing identifies candidate causative variants in consanguineous families with intellectual disability Intellectual and developmental disabilityExome/genome sequencingSNP analysis/discoveryVariant calling Poster Fri Oct 23 2:30 pm Low-Cost Whole-Genome Sequencing for Rare Variant Discovery in a Youth Psychiatric Cohort: A Pilot Study in the Toronto Adolescent and Youth (TAY) Cohort Psychiatric geneticsBioinformaticsRare variantsVariant calling |
Molecular Neuropsychiatry & Development (MiND) Labvincent-lab.com Works in rare disease.
| Poster Wed Oct 21 2:30 pm Expression and stability analysis of Rett Syndrome-causing MECP2 mutations. AutismNeurodevelopmentalProtein structureX-linked disease |
| 1 more presenter — research group not yet identified | |
Find decision makers at Centre for Addiction and Mental Health
Tell us what you sell and we’ll find the people at Centre for Addiction and Mental Health most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction